Thursday May 9 | Seeking Alpha
ImmunoGen's Symbiotic Relationships Thru TAP Will Beef Up Its Stock Price
ImmunoGen Inc. is going to be a very essential player in the biotech sector in the near future.
ImmunoGen, Inc. Announces Webcast of Presentation at Upcoming Investor Conference
ImmunoGen, Inc. , a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload antibody-drug conjugate technology, today announced that Gregory Perry, Executive Vice President and Chief Financial Officer, will present at the upcoming Credit Suisse Antibody Day in New York.
Jackpotpennystocks.com , an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following stock:- ImmunoGen, Inc.
ImmunoGen (IMGN) Announces Quarterly Results
ImmunoGen issued its quarterly earnings data on Friday. The company reported earnings per share for the quarter, beating the analysts' consensus estimate of by $0.13, Analyst Ratings.Net reports.
Customer Interaction Solutions
ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2013 Financial...
"Based on published clinical findings and patient anecdotes, we believe Kadcyla will make a notable difference for many patients and become a highly successful product," commented Daniel Junius, President and CEO.
ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2013 Financial...
"Based on published clinical findings and patient anecdotes, we believe Kadcyla will make a notable difference for many patients and become a highly successful product," commented Daniel Junius, President and CEO.